Researchers from Critical Path Institute’s® (C-Path) Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for detecting liver injury, supporting clearer decision-making.
GLDH proposed as a more accurate biomarker for liver injury detection
- Post author:admin
- Post published:March 28, 2025
- Post category:uncategorized
- Post comments:0 Comments